Axa’s Genesis Healthcare, Inc. GEN Stock Holding History

Axa’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,400	Closed	-$53K	–	1478
2015 Q1	$53K	Buy	+7,400	New	+$55.8K	﹤0.01%	1361

Other funds holding GEN

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Axa's GEN Position: Q2 2015 in Review

Axa sold out of Genesis Healthcare, Inc. (GEN) in Q2 2015, closing a stake of 7,400 shares — an estimated $53K sold.

Axa first reported a position in GEN in Q1 2015 and held it in 1 quarter. The position peaked at $53K in Q1 2015. 78 funds tracked by Wall St. Rank hold GEN as of Q2 2015.

Axa reported no remaining Genesis Healthcare, Inc. position as of Q2 2015 after selling out during the quarter.
Axa sold 7,400 Genesis Healthcare, Inc. shares in Q2 2015, an estimated $53K.
Axa first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 1 quarter.
Axa's Genesis Healthcare, Inc. position peaked at $53K in Q1 2015.
78 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2015.

Based on Axa's 13F filing for Q2 2015, filed 13 Aug 2015.